SLS: SELLAS Life Sciences Group Inc

SLS新闻

• 19:06 SELLAS: Imminent Catalyst, Dual-Platform Pipeline, And A Market That Hasn't Caught Up
• 15:28 Sellas Life Sciences: REGAL Trial's Delayed Events Signal Selection Bias (SLS)
• 16:40 This Little-Known Stock Has Surged 550% in the Past Year
• 17:55 Why Sellas Remains A Strong Sell After Doubling In Price (NASDAQ:SLS)
• 21:20 Biotech Is The Rate Cut Trade In Disguise
• 08:25 SELLAS Life Sciences: The AML Platform Is More Interesting Than Binary Event (NASDAQ:SLS)
• 14:54 SELLAS Stock Hits New Highs: What's Happening Today? - SELLAS Life Sciences Gr (NASDAQ:SLS)
• 16:07 Sellas Life Sciences: The Internal Inconsistency Of An Assumed Positive REGAL Readout
• 17:08 Sellas Life Sciences: REGAL Delay May Be A Warning Sign, Not A Bullish Signal (NASDAQ:SLS)
• 19:06 SELLAS Life Sciences "Hold" As Phase 3 AML Study Progresses To Key Event (NASDAQ:SLS)
• 13:55 Wall Street Analysts Think SELLAS Life Sciences Group, Inc. (SLS) Could Surge 66.09%: Read This Before Placing a Bet
• 16:00 All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to Buy
• 13:55 Wall Street Analysts Believe SELLAS Life Sciences Group, Inc. (SLS) Could Rally 63.58%: Here's is How to Trade
• 12:51 SELLAS在SLS009二期急性髓系白血病试验中完成首例患者入组
• 12:48 SELLAS enrolls first patient in Phase 2 AML trial of SLS009
• 20:13 Sellas Life Sciences报告权证行权收益达4260万美元
• 20:12 Sellas Life Sciences reports $42.6 million in warrant exercise proceeds